Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

NEW YORK--(BUSINESS WIRE)--Galloway Capital Partners, LLC (“Galloway”), together with its affiliates, today announced that it has accumulated an ownership stake of approximately 8.42% in WW International, Inc. (“WW” or the “Company”). Galloway believes WW is materially undervalued despite owning one of the world's most recognized wellness brands and operating in the rapidly growing markets of weight management, metabolic health, GLP-1 support, and longevity. Following its recent restructuring,.

Business Wire • May 13, 2026

WW International, Inc. (WW) Q1 2026 Earnings Call Transcript

WW International, Inc. (WW) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 11, 2026

WW International Q1 Earnings Call Highlights

WW International NASDAQ: WW, operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results that reflected continued pressure in its legacy behavioral subscription business, offset in part by growth in its clinical weight-management offering and higher-value membership tiers.

MarketBeat • May 9, 2026

Weight Watchers Announces First Quarter 2026 Results

Total End of Period Subscribers of 2.7 million; End of Period Clinical Subscribers of 197 thousand, up 46% year-over-year Revenue of $168 million; Clinical Subscription Revenue of $39 million, up 32% year-over-year Reaffirms Full Year 2026 Financial Guidance Announces Fully Subscribed Debt Prepayment Solicitation as Part of Actions Expected to Reduce Debt by $42 Million NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced its results for the first quarter of fiscal 2026 ended March 31, 20261 in this Earnings Press Release and a Shareholder Letter issued today and posted on the Company's Corporate Website . “We remain confident in our strategy to build the industry-leading weight health platform.

GlobeNewsWire • May 7, 2026

WW International Logs Lower Sales

WW International posted lower revenue in the first quarter, as behavioral subscription sales fell.

WSJ • May 7, 2026

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide)

The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetes

GlobeNewsWire • May 1, 2026

Weight Watchers Announces Actions to Utilize Up to $40 million to Pay Down Debt

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it intends to utilize up to $40 million in cash to prepay and reduce the principal amount of its outstanding term loan.

GlobeNewsWire • Apr 27, 2026

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the first quarter 2026 ended March 31, 2026, before market open on Thursday, May 7, 2026.

GlobeNewsWire • Apr 23, 2026

Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it has appointed Heather Thiltgen to the Company's Board of Directors, effective April 20, 2026. Ms. Thiltgen currently serves as the President of Presbyterian Health Plan and previously served as President & CEO of WellSense Health Plan.

GlobeNewsWire • Apr 20, 2026

Weight Watchers Announces Board Committee Appointments

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors' standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors: Audit Committee: Gene Davis (Chair), Sue Gove, Carney Hawks and Nikolaj Sjoqvist; Compensation and Benefits Committee: Carney Hawks (Chair), Gene Davis and Lisa Gavales; Nominating and Corporate Governance Committee: Nikolaj Sjoqvist (Chair), Gene Davis and Sue Gove; and Strategy and Finance Committee: Gene Davis (Chair), Lisa Gavales, Carney Hawks, Mike Mason and Nikolaj Sjoqvist. Office of the CEO Update As previously announced, the Board established a Transition Committee to oversee the Office of the CEO, which comprises Felicia DellaFortuna, the Company's Chief Financial Officer, and Jon Volkmann, the Company's Chief Operations Officer.

GlobeNewsWire • Apr 9, 2026